BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6767188)

  • 1. Splenectomy in the Wiskott-Aldrich syndrome.
    Nathan DG
    N Engl J Med; 1980 Apr; 302(16):916-7. PubMed ID: 6767188
    [No Abstract]   [Full Text] [Related]  

  • 2. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome.
    Lum LG; Tubergen DG; Corash L; Blaese RM
    N Engl J Med; 1980 Apr; 302(16):892-6. PubMed ID: 6767187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wiskott Aldrich syndrome: a treatable immune disorder. A review.
    Millikan LE
    Mo Med; 1973 Nov; 70(11):764-7 passim. PubMed ID: 4591682
    [No Abstract]   [Full Text] [Related]  

  • 4. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation.
    Parkman R; Rappeport J; Geha R; Belli J; Cassady R; Levey R; Nathan DG; Rosen FS
    N Engl J Med; 1978 Apr; 298(17):921-7. PubMed ID: 347289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Wiskott-Aldrich syndrome. Recent information apropos of 4 cases].
    Griscelli C; Phan-Huu-Trung ; Herzog C; Mozziconacci P
    Nouv Rev Fr Hematol; 1973; 13(4):554-68. PubMed ID: 4271105
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome.
    Litzman J; Jones A; Hann I; Chapel H; Strobel S; Morgan G
    Arch Dis Child; 1996 Nov; 75(5):436-9. PubMed ID: 8957959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Wiskott-Aldrich syndrome: the possibilities of diagnosis and treatment].
    Krisiukeniene A; Sitkauskiene B; Sakalauskas R
    Medicina (Kaunas); 2003; 39(3):211-6. PubMed ID: 12695631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago.
    Lang P; Klingebiel T; Schumm M; Handgretinger R; Greil J; Beck JF; Niethammer D; Bader P
    Bone Marrow Transplant; 2004 Apr; 33(8):879-80. PubMed ID: 14743191
    [No Abstract]   [Full Text] [Related]  

  • 9. [Wiskott-Aldrich syndrome (literature review)].
    Shabalov NP
    Vopr Okhr Materin Det; 1975 Feb; 20(2):50-4. PubMed ID: 1094723
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone marrow transplantation for Wiskott-Aldrich syndrome: report of 2 cases with use of 2-mercaptoethane sulfonate.
    Goldsobel AB; Ehrlich RM; Mendoza GR; Stiehm ER
    Transplantation; 1985 May; 39(5):568-70. PubMed ID: 3922097
    [No Abstract]   [Full Text] [Related]  

  • 11. The Wiskott-Aldrich syndrome.
    Ormerod AD
    Int J Dermatol; 1985 Mar; 24(2):77-81. PubMed ID: 3886570
    [No Abstract]   [Full Text] [Related]  

  • 12. Eczema in primary immune-deficiencies. Clues to the pathogenesis of atopic dermatitis with special reference to the Wiskott-Aldrich syndrome.
    Saurat JH
    Acta Derm Venereol Suppl (Stockh); 1985; 114():125-8. PubMed ID: 3890446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful bone marrow transplantation in an infant with Wiskott-Aldrich syndrome.
    Mathew LG; Chandy M; Dennison D; Srivastava A; Ganapathy K; Cherian T
    Indian Pediatr; 1999 Jul; 36(7):707-10. PubMed ID: 10740310
    [No Abstract]   [Full Text] [Related]  

  • 14. Marrow transplantation for nonmalignant disorders.
    Thomas ED
    N Engl J Med; 1978 Apr; 298(17):963-4. PubMed ID: 417247
    [No Abstract]   [Full Text] [Related]  

  • 15. Unrelated bone marrow transplantation in a Wiskott-Aldrich syndrome patient sharing two HLA-extended haplotypes with the donor.
    La Nasa G; Pizzati A; Ledda A; Vacca A; Arras M; Contu L
    Haematologica; 1996; 81(2):178-81. PubMed ID: 8641653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of the Wiskott-Aldrich syndrome by a graft of allogeneic bone marrow].
    Fischer A; Durandy A; Bordigoni P; Virelizier JL; Vilmer E; Arnaud-Battandier F; Lagrue A; Olive D; Griscelli C
    Arch Fr Pediatr; 1984 Nov; 41(9):611-6. PubMed ID: 6391414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update of the Wiskott-Aldrich syndrome. From a new case report.
    Martín Mateos MA; Muñoz-López F; Cruz M
    Allergol Immunopathol (Madr); 1988; 16(2):113-9. PubMed ID: 3394592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wiskott-Aldrich syndrome.
    Notarangelo LD; Miao CH; Ochs HD
    Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethics of using a bone marrow donor with Klinefelter syndrome.
    McGovern MM; Rhodes R
    Pediatr Transplant; 2008 Aug; 12(5):496-8. PubMed ID: 18537900
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich Foundation.
    Shah AJ; Sokolic R; Logan B; Yin Z; Iyengar S; Scalchunes C; Mangurian C; Albert M; Cowan MJ
    J Clin Immunol; 2019 Nov; 39(8):786-794. PubMed ID: 31620947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.